Nobody in the room spoke for several seconds after Dr. Adrian Cole fell silent.
Rachel sat upright in the hospital bed, one hand resting low across her abdomen.
She looked exhausted.
Not weak.
There was a difference.
“What consortium?” Grace asked.
Dr. Cole hesitated.
“The sequence is associated with a group of licensed technologies held across several institutions.”
“That is not an answer.”
“I understand.”
“No,” Grace said. “You understand how to avoid one.”
I almost smiled.
Rachel did not.
She leaned toward the phone.
“Name them.”
Another pause.
“Atlas Genomic Holdings.”
Julian, who had joined the call remotely from Lake Travis, swore softly through the speaker.
Michael looked at Grace.
“You know them?”
Grace shook her head.
Julian answered.
“I do.”
“How?”
“They hold legacy patents from old Voss collaborations.”
Mara’s company.
Harlan’s downstream research.
The network was beginning to take shape beyond our family.
Rachel looked at the phone.
“Did Atlas buy data from Harlan Vale?”
Cole replied carefully.
“Atlas acquired intellectual property from several predecessor entities.”
“That means yes.”
“I did not say that.”
“You did not need to.”
Ortiz stood near the window with her arms crossed.
“Dr. Cole, are you representing the consortium?”
“No.”
“Then why are you calling?”
“I was asked to notify you that the sequence may be subject to ownership claims.”
Rachel laughed.
Not pleasantly.
“Ownership.”
Cole said, “Mrs. Whitmore—”
“Rachel.”
“Rachel, I understand how that sounds.”
“No. I do not think you do.”
She shifted upright.
“My pregnancy was created from an embryo taken from me and Daniel without consent. The embryo was edited without consent. It was implanted without consent. The fetus apparently carries a sequence inserted through crimes committed by people who treated our family like laboratory equipment.”
No one moved.
Rachel continued.
“And now somebody wants to inform me that a corporation may own that sequence.”
Cole spoke more slowly.
“The legal status is not that simple.”
Rachel’s voice sharpened.
“It is simple from this side.”
“Legally, patent rights can attach to engineered sequences—”
“Not to my child.”
“I did not say Atlas owns your child.”
“You said the sequence inside my child is proprietary.”
“Yes.”
“Then what exactly do they think ownership gives them?”
Silence.
That was the real question.
Grace leaned forward.
“Can they demand samples?”
“No.”
“Can they restrict testing?”
“Possibly, depending on the specific assay and jurisdiction.”
Michael shook his head.
“That would be challenged immediately.”
Cole said, “Yes.”
“Can they stop us publishing the watermark?”
“Potentially.”
Julian’s voice came through the speaker.
“That is what this is.”
Everyone looked toward the tablet.
He continued.
“They are not worried about the pregnancy.”
Rachel’s face hardened.
“They are worried the watermark exposes which patents came from Harlan’s stolen material.”
Julian said, “Exactly.”
Cole did not deny it.
Ortiz stepped closer to the phone.
“Dr. Cole, you should understand that this conversation may become evidence.”
“I assumed it would.”
“Good.”
She looked at Rachel.
“Keep asking questions.”
Rachel did.
“How many Atlas patents contain sequences matching Margaret’s watermark?”
Cole answered too quickly.
“I don’t know.”
Grace stared.
“Then why call us?”
“I was informed there were overlaps.”
“How many?”
“I genuinely do not know.”
Michael asked, “Who informed you?”
Cole hesitated.
“Atlas legal counsel.”
“Name.”
“I am not authorized—”
Ortiz cut in.
“Name.”
Another pause.
“Elliot Vane.”
Julian reacted immediately.
“No.”
I looked at the tablet.
“You know him.”
“Yes.”
“How?”
“He was outside counsel for Voss Biotech.”
Grace’s eyes narrowed.
“Mara.”
“Yes.”
“He helped her?”
“I don’t know.”
Leah, standing against the far wall, laughed bitterly.
“Family motto.”
Julian ignored her.
“Vane handled patent transfers from old Vale-linked entities.”
Michael’s face tightened.
“So if he is calling Cole now, he knows the watermark threatens chain of title.”
Rachel looked at me.
“English.”
I answered.
“They may have patents built from research that was never legally theirs.”
Grace nodded.
“And if the watermark proves that, ownership can be challenged.”
Rachel stared toward the phone.
“So they are trying to get ahead of it.”
Cole said, “That is one interpretation.”
Leah muttered, “Very charitable.”
Rachel asked, “What happens if we release the full sequence publicly?”
Cole paused.
“Potential litigation.”
“Against whom?”
“Potentially against anyone distributing protected sequence data.”
Rachel stared.
“You are threatening us.”
“No.”
“You are delivering someone else’s threat politely.”
Cole exhaled.
“That is fair.”
His honesty surprised the room.
He continued.
“I called because I believe you should have counsel before speaking to Atlas.”
Ortiz looked at the phone differently.
“Why help them?”
“I am not helping Atlas.”
“Then why are you involved?”
Cole hesitated.
“Because I reviewed the sequence.”
Grace’s face changed.
“How did you get it?”
Another pause.
“An internal contact.”
Rachel looked toward Mara’s guards.
“Mara?”
“No.”
Julian leaned forward on the tablet.
“Who?”
Cole did not answer.
Ortiz’s voice hardened.
“Dr. Cole.”
“The file was sent anonymously.”
“When?”
“Forty minutes ago.”
Grace stared.
“After the watermark confirmation.”
“Yes.”
“Who else has it?”
“I don’t know.”
“Have you uploaded it anywhere?”
“No.”
“Copied it?”
“Yes.”
“For analysis.”
“Delete it.”
Cole paused.
“I can’t ethically erase medical evidence.”
Rachel nodded once.
“Good answer.”
Grace looked at her mother.
Rachel continued.
“But you will not share it.”
“I will not.”
Ortiz asked, “Can you identify anything clinically useful?”
Cole hesitated.
“Yes.”
Everyone went still.
Rachel’s hand tightened.
“What?”
“The watermark is not only a tag.”
Michael leaned closer.
“What else?”
Cole continued.
“It includes regulatory elements.”
Grace frowned.
“Regulatory for what?”
“The temporary suppressor expression.”
My stomach tightened.
“You are saying Margaret’s tag controls the synthetic treatment effect.”
“Partly.”
Michael stared.
“That contradicts the sixteen-week protocol.”
“Not necessarily.”
“How?”
Cole answered.
“The shutdown signal may be coupled to the watermark architecture.”
Grace looked at Michael.
“So if we understand the watermark—”
“We may be able to modify shutdown.”
Rachel’s eyes widened.
“Stop the sixteen-week clearance?”
“Possibly.”
There was that word again.
But this time possibility meant another option.
Rachel leaned forward.
“Without fetal intervention?”
Cole answered carefully.
“Potentially through maternal therapy.”
Grace’s face changed.
“Targeted RNA?”
“Yes.”
Michael stared at the phone.
“You’ve seen this before.”
Cole went silent.
Julian noticed too.
“Adrian.”
It was the first time he used Cole’s first name.
“You recognize the architecture.”
Cole exhaled.
“Yes.”
Rachel stared.
“From where?”
“The National Center has been studying a related sequence for six years.”
Michael went rigid.
“Related to Harlan?”
“We did not know the origin.”
“You do now.”
“Yes.”
“And your center has patents?”
“No.”
“Atlas?”
“Yes.”
The room went cold again.
Rachel whispered, “They have already turned this into medicine.”
Cole answered.
“Partially.”
“How many patients?”
“Clinical trial participants?”
“Yes.”
“Forty-two.”
Grace stared.
“Consenting?”
“Yes.”
“Fully informed about the sequence origin?”
“No.”
Silence.
Because nobody had known.
Cole continued.
“The treatment is experimental but promising in certain repair-deficient cancers.”
Rachel looked at Michael.
“My cancer.”
“Possibly.”
Cole said, “The mechanism resembles what we see in your pregnancy.”
Grace whispered, “So Harlan’s stolen research became an actual therapy.”
“Yes.”
Rachel closed her eyes.
The cruelty had changed shape again.
What Harlan did remained wrong.
But something medically useful had grown from it.
That did not redeem the crime.
It complicated what came next.
“What happens to those forty-two patients if the patent collapses?” Rachel asked.
Cole paused.
“Nothing immediate medically.”
“Access?”
“Could become legally complicated.”
“Price?”
“Possibly.”
“Trial continuation?”
“Potentially.”
Rachel opened her eyes.
“So if we expose Atlas, patients could lose treatment.”
Cole answered carefully.
“Not necessarily, but there is risk.”
There it was.
Another choice someone might try to force.
Truth versus treatment.
Victims versus patients.
Rachel almost laughed.
“I know this trick.”
Cole said nothing.
“They want me to think exposing theft means hurting sick people.”
“I am not saying that.”
“Somebody will.”
“Yes.”
Rachel looked at Ortiz.
“Can Atlas stop us getting medical advice?”
“No.”
“Can they stop treatment?”
“Not directly.”
“Can they sue?”
“Almost certainly.”
“Fine.”
I looked at her.
“Fine?”
She turned to me.
“I am done letting the possibility of consequences become permission for silence.”
Grace smiled faintly.
Leah said, “That sounded expensive.”
Rachel almost smiled.
“Probably.”
Ortiz’s phone buzzed.
She read.
“What?”
“Federal investigators want immediate access to the watermark comparison.”
Rachel looked at her.
“Do they get it?”
Ortiz paused.
“It is your medical data.”
Rachel looked at me.
Then Grace.
Then back at Ortiz.
“I want a copy preserved under independent court seal.”
“Good.”
“Another copy to the federal investigators.”
“Okay.”
“And a medical copy to Dr. Cole’s center only for treatment analysis.”
Cole spoke from the phone.
“We can set up a protected clinical review.”
“No patent use.”
“I cannot promise what the law—”
“No.”
Rachel’s voice hardened.
“You want access to my medical sequence to help me. You get it for that purpose. Not commercialization.”
Cole paused.
Then said, “I agree.”
Ortiz looked impressed.
Grace looked proud.
I was too.
Rachel continued.
“And I want patient advocates for the forty-two trial participants informed once law enforcement clears it.”
Cole said, “That will be complicated.”
“Yes.”
“Possibly destabilizing.”
“Yes.”
“It could frighten them.”
Rachel’s expression hardened.
“They are adults.”
Cole went silent.
“They get to know.”
“Yes.”
The sentence settled through the room.
Choice again.
Not easy.
Not clean.
Still theirs.
Ortiz received another call.
She stepped into the hallway.
Michael looked at Rachel.
“There is one more medical issue.”
Rachel groaned.
“Only one?”
“For this five minutes.”
“Go.”
“If Atlas has worked with this sequence, their data could help us predict the sixteen-week shutdown.”
“Can we compel it?”
Grace asked.
“Maybe through regulators.”
Rachel looked at Cole’s phone line.
“Or ask.”
Cole replied, “I can request access.”
“Will they cooperate?”
“No.”
“Why not?”
“Because giving you raw development data may expose how much of their work came from Harlan.”
Leah laughed.
“Then subpoena it.”
Ortiz returned.
“We may not have to.”
Everyone looked at her.
“Federal agents executed warrants on Atlas Genomic Holdings twenty minutes ago.”
Rachel blinked.
“Already?”
“The public archive index triggered multiple investigations.”
Mara had unleashed chaos.
But some of it was finally reaching the people who had profited.
Ortiz continued.
“Servers are being imaged.”
Michael leaned forward.
“Any clinical data?”
“Unknown.”
“Any executive arrests?”
“Not yet.”
Rachel asked, “Elliot Vane?”
Ortiz’s expression changed.
“Missing.”
Of course.
“When last seen?”
“Yesterday.”
Julian looked worried.
“He has access to Mara’s corporate credentials.”
My stomach tightened.
“The lake archive transfer.”
“Yes.”
“He could have used her company.”
“Possibly.”
Grace frowned.
“So Mara may not have initiated every transfer under her name.”
Julian nodded.
Leah sighed.
“Credentials again.”
Rachel stared toward Mara’s guarded room.
“She still released the public index.”
“Yes.”
“But maybe not the full archive.”
Ortiz nodded slowly.
“That remains possible.”
I thought about the message sent with Rachel’s photograph.
Save your wife.
Mara denied involvement in the pregnancy.
David did not know the embryo was edited.
Harlan knew but did not own every move.
Now Elliot Vane appeared.
A lawyer.
Not scientist.
Not family.
Someone who understood patents, ownership, corporate risk.
Maybe the next threat really did wear a suit.
Ortiz’s phone buzzed again.
She read the message.
Then looked at Rachel.
“What?”
“They found Vane’s car.”
“Where?”
“Philadelphia.”
Grace went still.
“The fetal therapy center.”
Everyone understood at once.
Rachel had asked for a consultation there.
Only a small circle knew.
“Does he know we’re going?” I asked.
Ortiz looked grim.
“Apparently.”
Rachel stared.
“Then we don’t go.”
Grace immediately said, “Mom.”
Rachel held up a hand.
“I did not say cancel the consultation.”
“What then?”
“We change how.”
I looked at her.
“How?”
Rachel’s eyes sharpened.
“He expects me to arrive as a patient being protected.”
“Yes.”
“So we stop behaving like prey.”
Ortiz almost smiled.
“That sounds like a law-enforcement suggestion.”
“No.”
Rachel looked toward the guarded rooms holding Mara and David.
“It sounds like something I learned from surviving everyone who thought fear would make me predictable.”
A plan took shape over the next hour.
The consultation would proceed remotely first.
The specialized fetal therapy team would review imaging and sequence data through a secure federal channel.
No travel until the route was controlled.
No public schedule.
No hospital directly connected to Harlan.
Rachel stayed exactly where she was.
For once, refusing movement became action.
The Philadelphia team joined by video.
Three physicians.
One bioethicist.
One genetic counselor.
No corporate representatives.
Rachel asked every question herself.
Could the sixteen-week shutdown be modified?
Possibly.
Could pregnancy continue safely?
Possibly.
Could cancer treatment continue?
In adjusted form.
Could they guarantee anything?
No.
That answer made Rachel trust them more.
Then Dr. Priya Nandakumar, the fetal therapy specialist, looked closely at the sequence.
“This tag.”
Grace leaned toward the monitor.
“What?”
“I’ve seen a derivative before.”
Everyone froze.
“Where?”
“In a fetal repair trial proposal.”
Michael stared.
“Atlas?”
“No.”
“Voss?”
“No.”
Dr. Nandakumar checked her records.
“Submitted nine years ago by an independent researcher.”
“Name?”
She looked at the file.
“Dr. Margaret Vale.”
Silence.
Mara’s first name was not Margaret.
Anna’s daughter was Mara.
Michael’s mother Anna.
My mother Margaret Whitmore.
No Dr. Margaret Vale existed in our story.
At least not yet.
I looked at Ortiz.
“Who is she?”
Ortiz was already searching.
Dr. Nandakumar continued.
“The proposal was withdrawn before review.”
“Do you have contact details?”
“Old institutional address.”
“Where?”
She read it.
Everyone looked at Mara through the glass.
Mara had gone pale.
She knew the institution.
Julian recognized it too.
“What?” I asked.
Julian whispered, “That was Mara’s doctoral lab.”
Grace stared.
“Mara used another name.”
Mara shook her head through the glass.
“No.”
Ortiz entered her room.
We watched through the window.
“Mara, who is Margaret Vale?”
Mara stared at her.
“I don’t know.”
“Your doctoral lab submitted a proposal under that name.”
Mara’s face changed.
Not recognition.
Fear.
Then she whispered, “Oh God.”
“What?”
She looked toward us.
“Harlan had another daughter.”
The room froze.
Mara continued.
“Older than me.”
Anna stood abruptly.
“No.”
Mara looked at her biological mother through the glass.
“Yes.”
Anna’s face collapsed.
“With whom?”
Mara whispered, “Margaret Whitmore.”
I stopped breathing.
My mother.
My mother had a child with Harlan.
PART 37 TITLE continued — the room itself seemed to tilt beneath everything we thought we knew.
I stared at Mara.
“Say that again.”
She looked sick.
“Harlan told me Margaret became pregnant once.”
“That is not possible.”
Anna whispered, “It is.”
Everyone turned toward her.
She looked at me.
“I thought the baby died.”
Of course.
Always the same sentence.
I closed my eyes.
“When?”
“Before you were born.”
My mother Margaret.
Married to Samuel.
Pregnant with Harlan’s child.
Another hidden branch.
Another child someone declared dead.
Mara whispered, “Harlan called her Maggie.”
Rachel stared through the glass.
“Margaret Vale.”
Grace looked at the Philadelphia team still connected on screen.
“Can you send the proposal?”
Dr. Nandakumar nodded.
Minutes later it arrived.
The photograph attached to the old institutional profile showed a woman in her early forties.
Gray eyes.
Dark hair.
A familiar mouth.
My mother’s mouth.
Mara’s eyes.
Rachel whispered, “She’s real.”
Name:
Dr. Margaret Vale.
Specialty:
Molecular genetics.
Status:
Deceased.
Date of death:
Eight years ago.
The same year my mother Margaret died.
I stared.
“Same year.”
Ortiz checked.
Different states.
Different causes.
At least on paper.
Then Grace opened the withdrawn fetal repair proposal.
The first line changed everything again.
The watermark system described was not credited to Harlan.
It was credited to M. Whitmore and M. Vale.
My mother.
And her hidden daughter.
Margaret had not merely helped Anna modify embryo three.
She had worked with her own daughter.
A daughter I never knew existed.
Rachel looked at me.
“Danny.”
I could not answer.
For once, the secret did not make me angry first.
It made me tired.
So tired.
Then Grace read the final page.
Dr. Margaret Vale had withdrawn the proposal because she believed the technology could be misused for nonconsensual reproductive engineering.
She had written one sentence by hand.
If my father ever finds this architecture, destroy every copy.
Harlan had found it anyway.
But maybe not all of it.
Maybe the sequence inside Rachel’s pregnancy was not Harlan’s design.
Maybe it was a warning built by women trying to stop him.
And if Dr. Margaret Vale had died eight years ago, someone else had revived her work.
The question was no longer only who.
It was why.
Click here to continue reading: PART 38: Margaret Vale’s Hidden Research Revealed a Daughter Raised Against Harlan, and Her Death Connected Elliot Vane to the Watermark’s Revival
Three Years After Our Divorce, Rachel Left Her Wedding Ring on My Pillow and Vanished Before I Woke
Part 37 of 43
